Suja Life Inc

Análisis de la acción Suja Life Inc (SUJA)

$9.840

+0.132 (+1.34%)Al cierre

Loading chart…
Máximo
10.040
Apertura
9.770
Precio medio ponderado por volumen
9.81
Volumen
79.76K
Capitalización
—
Mínimo
9.540
Importe
782.21K
EV/EBITDA, TTM
10.75

Suja Life, Inc. is a beverage platform. The Company operates at the intersection of health, taste, and trust, offering cold-pressed juices, wellness shots, and functional sodas that have become an essential part of consumers' everyday routines. Its brands include Suja Organic, Vive Organic, and Slice. Suja Organic is its flagship brand, known for its organic cold-pressed juices and wellness shots.it includes a green juice platform, boosted juice platform, refreshers platform, and wellness shots platform. Vive Organic is a wellness shot brand, known for the functional shot category with its doctor-crafted formulations and redefining how consumers approach proactive wellness. It offers an immunity boost platform, energy boost platform, and pure boost platform. Slice offers an original better-for-you soda, made with 10% real fruit juice and also with prebiotics, probiotics, postbiotics, reduced sugar, and no artificial ingredients.

www.sujalife.com

Análisis de IA of Suja Life Inc (SUJA)

Comprar

Suja Life, Inc. is a good buy right now due to its recent strong Q2 earnings with net sales of $83.9 million, reflecting an 11.6% year-over-year increase, and a gross margin of 48.86%. Despite a current price of $9.84 and a significant year-to-date decline of 53.14%, the stock is viewed positively by analysts, with a target price as high as $20, indicating substantial upside potential. The main risk is the company's high debt-to-equity ratio of 86.31%, which could impact financial stability if not managed properly.

Métricas de valoración

El PER previsto actual de Suja Life Inc (SUJA) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
11.05
EV/EBITDA actual
10.75
Sobrevalorada
17.61
Infravalorada
4.49

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.80
P/S actual
0.92
Sobrevalorada
0.99
Infravalorada
0.60

Cronología de eventos

2026-09-21 (ET)

09:00:00

Suja Life Appoints Michael Mougias as Head of Investor Relations

2026-08-04 (ET)

18:30:00

Paine Schwartz Partners Plans to Buy Suja Life Class A Common Stock in Open Market

17:00:00

Company Reports Q2 Revenue of $83.9M, Exceeds Expectations

17:00:00

Sees FY26 Adjusted EBITDA of $70M-$72M

2026-05-11 (ET)

11:30:00

Mobia Medical, Odyssey Therapeutics and Others Go Public This Week

Noticias

Preguntas frecuentes sobre SUJA, respondidas por Alphio AI

Suja Life, Inc. is a beverage platform. The Company operates at the intersection of health, taste, and trust, offering cold-pressed juices, wellness shots, and functional sodas that have become an essential part of consumers' everyday routines. Its brands include Suja Organic, Vive Organic, and Slice. Suja Organic is its flagship brand, known for its organic cold-pressed juices and wellness shots.it includes a green juice platform, boosted juice platform, refreshers platform, and wellness shots platform. Vive Organic is a wellness shot brand, known for the functional shot category with its doctor-crafted formulations and redefining how consumers approach proactive wellness. It offers an immunity boost platform, energy boost platform, and pure boost platform. Slice offers an original better-for-you soda, made with 10% real fruit juice and also with prebiotics, probiotics, postbiotics, reduced sugar, and no artificial ingredients. It operates in the Consumer Non-Cyclicals sector.

Suja Life, Inc. is a good buy right now due to its recent strong Q2 earnings with net sales of $83.9 million, reflecting an 11.6% year-over-year increase, and a gross margin of 48.86%. Despite a current price of $9.84 and a significant year-to-date decline of 53.14%, the stock is viewed positively by analysts, with a target price as high as $20, indicating substantial upside potential. The main risk is the company's high debt-to-equity ratio of 86.31%, which could impact financial stability if not managed properly.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar